Home › Depression › California › Irvine
Depression clinical trials in Irvine, CA
4 studies for Depression are looking for participants at sites in and around Irvine (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Kaiser Permanente-Irvine, Irvine
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Irvine Clinical Research, Irvine
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Irvine
Positive Affect Treatment for Adolescents With Early Life Adversity
RecruitingHealthy volunteers welcome
- University of California Irvine, Irvine
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA50 studies
- New York City, NY44 studies
- Chicago, IL26 studies
- Atlanta, GA22 studies
- Pittsburgh, PA22 studies
- Philadelphia, PA21 studies
- Charleston, SC18 studies
- San Diego, CA18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Washington, DC16 studies
- San Francisco, CA15 studies
Other studies in Irvine
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer23 studies
- Cancer (all types)18 studies
- Metastatic Cancer16 studies
- Lung Cancer15 studies
- Ovarian Cancer14 studies
- Prostate Cancer14 studies
- Multiple Myeloma14 studies
- Alzheimer's Disease12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Bladder Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.